SK pharmteco
Timothy Buckley has extensive experience in the pharmaceutical industry, with their most recent role being Vice President of Global Quality at SK pharmteco since 2018. Prior to this, they held various positions at Bristol-Myers Squibb, including Head of Quality BMS Internal Pharma Manufacturing and Quality Director, starting in 2012. From 2003 to 2012, Timothy worked at Pfizer Ireland Newbridge as Director of Quality/Quality Operations Product Leader/QP. Earlier in their career, they served as QA/Validation Manager at Merck from 1996 to 2003 and as a Validation Specialist at Leo Pharmaceuticals from 1993 to 1996.
Timothy Buckley obtained a Bachelor of Applied Science (B.Sc., Applied Physics & Applied Chemistry) from Trinity College Dublin in the years 1985 to 1989. Timothy then pursued a Master of Science (M.Sc) in Analytical Chemistry from Dublin City University from 1990 to 1992. In 1995, they received ASME membership from Technological University Dublin. Lastly, in 2004 to 2005, they completed a Post grad Dip in Pharmaceutical Manufacture (QP) from Trinity College Dublin.
This person is not in any offices
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.